000			02365 a2200709 4500
005			20250517192116.0
264		0	_c20181005
008			201810s 0 0 eng d
022			_a1433-8726
024	7		_a10.1007/s00345-017-2154-x _2doi
040			_aNLM _beng _cNLM
100	1		_aKlatte, Tobias
245	0	0	_aPrognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting. _h[electronic resource]
260			_bWorld journal of urology _cMar 2018
300			_a417-425 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAged
650	0	4	_aAnilides _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCarcinoma, Renal Cell _xblood
650	0	4	_aCohort Studies
650	0	4	_aCombined Modality Therapy
650	0	4	_aCytoreduction Surgical Procedures _xmethods
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIndazoles
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aKidney Neoplasms _xblood
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aNeoplasm Metastasis
650	0	4	_aNephrectomy _xmethods
650	0	4	_aNivolumab
650	0	4	_aProbability
650	0	4	_aPrognosis
650	0	4	_aProportional Hazards Models
650	0	4	_aPyridines _xtherapeutic use
650	0	4	_aPyrimidines _xtherapeutic use
650	0	4	_aPyrroles _xtherapeutic use
650	0	4	_aRetrospective Studies
650	0	4	_aSex Factors
650	0	4	_aSulfonamides _xtherapeutic use
650	0	4	_aSunitinib
650	0	4	_aSurvival Rate
650	0	4	_aThrombocytosis _xblood
700	1		_aFife, Kate
700	1		_aWelsh, Sarah J
700	1		_aSachdeva, Manavi
700	1		_aArmitage, James N
700	1		_a'Aho, Tevita
700	1		_aRiddick, Antony C
700	1		_aMatakidou, Athena
700	1		_aEisen, Tim
700	1		_aStewart, Grant D
773	0		_tWorld journal of urology _gvol. 36 _gno. 3 _gp. 417-425
856	4	0	_uhttps://doi.org/10.1007/s00345-017-2154-x _zAvailable from publisher's website
999			_c27904155 _d27904155